tiprankstipranks
TipRanksTop Financial ExpertsInsidersDavid Gill

David Gill Insider Profile

11 Followers
David Gill, Director at Evolus, holds 86.89K shares in Evolus (Ticker: EOLS), holds 0.00 shares in Y-Mabs Therapeutics (Ticker: YMAB), holds 78.06K shares in Strongbridge Biopharma (Ticker: SBBP).
See the Hottest Stocks Based on Insider Trading >
tipranks
David Gill

David Gill
Evolus (EOLS)
Director

Ranked #55,164 out of 109,030 Corporate Insiders

Profitable Transactions

64%
7 out of 11 Profitable Transactions

Average Return

-0.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$1M
55.14%
44.39%
0.47%
0.00%
A breakdown of David Gill's holdings
See the Top Stocks by Insiders

Insider Roles

Evolus
(EOLS)
Director
Lemaitre Vascular
(LMAT)
Director
Strata Skin Sciences
(SSKN)
Director
Ocugen
(OCGN)
Director
Roles that David Gill holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Ocugen
(OCGN)
Rating:Informative Buy
Date:Aug 17, 2017 - Aug 17, 2018
Return:+48.70%
The most profitable trade made by David Gill
See the Latest Stocks Traded by Insiders

David Gill's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EOLS
Evolus
Feb 19, 2026
Director
Uninformative Buy
―
$681.19K
SSKN
Strata Skin Sciences
Nov 26, 2019
Director
Uninformative Buy
―
$5.82K
YMAB
Y-Mabs Therapeutics
Sep 18, 2025
―
Uninformative Sell
50.09K
$0.00
SBBP
Strongbridge Biopharma
Oct 05, 2021
―
Uninformative Sell
36.59K
$156.12K
GI
EndoChoice Holdings
Nov 23, 2016
―
Uninformative Sell
1.31M
$1.14M
MLNTQ
Melinta Therapeutics
May 30, 2018
―
Informative Buy
30.45K
$660.00
OCGN
Ocugen
Aug 17, 2017
Director
Informative Buy
5.43K
$0.00
NXTM
NxStage Medical
―
―
―
$223.26K
LMAT
Lemaitre Vascular
―
Director
―
$548.41K
List of latest transactions for each holding click on a transaction to see David Gill's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

David Gill insider profile FAQ

What is the percentage of profitable transactions made by David Gill?
The percentage of profitable transactions made by David Gill is 64%.
    What is the average return per transaction made by David Gill?
    The average return per transaction made by David Gill is -0.20%.
      What stocks does David Gill hold?
      David Gill holds: EOLS, SSKN, YMAB, SBBP, GI, MLNTQ, OCGN, NXTM, LMAT stocks.
        What was David Gill’s latest transaction?
        David Gill latest transaction was an Uninformative Buy of ―.
          What was David Gill's most profitable transaction?
          David Gill’s most profitable transaction was an Informative Buy of OCGN stock on August 17, 2017. The return on the trade was 48.70%.
            What is David Gill's role in Evolus?
            David Gill's role in Evolus is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.